id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0597-0058,FDA,FDA-2011-D-0597,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Guidance for Industry on Oversight of
Clinical Investigations: A Risk-Based Approach to Monitoring",Notice,30 Day Proposed Information Collection,2015-12-17T05:00:00Z,2015,12,2015-12-17T05:00:00Z,2016-01-20T04:59:59Z,2015-12-17T14:54:03Z,2015-31695,0,0,0900006481db6a1d
FDA-2011-D-0597-0055,FDA,FDA-2011-D-0597,"Agency Information Collection Activities; Proposed Collection;
Comment Request; Guidance for Industry on Oversight of Clinical
Investigations: A Risk-Based Approach To Monitoring",Notice,60 Day Proposed Information Collection,2015-07-14T04:00:00Z,2015,7,2015-07-14T04:00:00Z,2015-09-15T03:59:59Z,2015-09-12T01:30:55Z,2015-17318,0,0,0900006481b82f1c